S43ZeOxaNMulti trial: a randomized, double-blinded, placebo-controlled trial of oral zeolite “Multizeo Med” (based on PMA-zeolite – a double activated zeolite clinoptilolite called also Panalite) to prevent chemotherapy-induced side effects, in particular peripheral neuropathy / Vitale, M. G.; Barbato, C.; Habetswallner, Francesco; De Martino, B. M.; Sirico, F.; Crispo, A.; Cartenì, G.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 27:suppl_4(2016), pp. iv119-iv119. [10.1093/annonc/mdw345.43]
S43ZeOxaNMulti trial: a randomized, double-blinded, placebo-controlled trial of oral zeolite “Multizeo Med” (based on PMA-zeolite – a double activated zeolite clinoptilolite called also Panalite) to prevent chemotherapy-induced side effects, in particular peripheral neuropathy
HABETSWALLNER, Francesco;Sirico, F.;
2016
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
